Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease
(2022) In Brain : a journal of neurology 145(9). p.3035-3057- Abstract
Huntington's disease (HD) is a neurodegenerative disorder caused by CAG expansions in the huntingtin (HTT) gene. Modelling Huntington's disease is challenging, as rodent and cellular models poorly recapitulate the disease as seen in aging humans. To address this, we generated induced neurons (iNs) through direct reprogramming of human skin fibroblasts, which retain age-dependent epigenetic characteristics. HD-iNs displayed profound deficits in autophagy, characterised by reduced transport of late autophagic structures from the neurites to the soma. These neurite-specific alterations in autophagy resulted in shorter, thinner and fewer neurites specifically in HD-iNs. CRISPRi-mediated silencing of HTT did not rescue this phenotype but... (More)
Huntington's disease (HD) is a neurodegenerative disorder caused by CAG expansions in the huntingtin (HTT) gene. Modelling Huntington's disease is challenging, as rodent and cellular models poorly recapitulate the disease as seen in aging humans. To address this, we generated induced neurons (iNs) through direct reprogramming of human skin fibroblasts, which retain age-dependent epigenetic characteristics. HD-iNs displayed profound deficits in autophagy, characterised by reduced transport of late autophagic structures from the neurites to the soma. These neurite-specific alterations in autophagy resulted in shorter, thinner and fewer neurites specifically in HD-iNs. CRISPRi-mediated silencing of HTT did not rescue this phenotype but rather resulted in additional autophagy alterations in ctrl-iNs, highlighting the importance of wild type HTT in normal neuronal autophagy. In summary, our work identifies a distinct subcellular autophagy impairment in adult patient derived Huntington's disease neurons and provides a new rational for future development of autophagy activation therapies.
(Less)
- author
- organization
-
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- MultiPark: Multidisciplinary research focused on Parkinson´s disease
- Molecular Neurogenetics (research group)
- Wallenberg Neuroscience Centre, Lund
- Developmental and Regenerative Neurobiology (research group)
- Clinical Chemistry, Malmö (research group)
- Biomarkers and epidemiology
- Tumor microenvironment
- Mass Spectrometry
- BioMS (research group)
- Clinical Protein Science and Imaging (research group)
- Department of Biomedical Engineering
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Brain : a journal of neurology
- volume
- 145
- issue
- 9
- pages
- 3035 - 3057
- publisher
- Oxford University Press
- external identifiers
-
- scopus:85138449514
- pmid:34936701
- ISSN
- 1460-2156
- DOI
- 10.1093/brain/awab473
- language
- English
- LU publication?
- yes
- additional info
- © The Author(s) 2021. Published by Oxford University Press on behalf of the Guarantors of Brain.
- id
- 7b6bcad7-d1ac-49f3-b38e-2624e13c2988
- date added to LUP
- 2022-03-03 15:23:20
- date last changed
- 2024-11-16 10:05:53
@article{7b6bcad7-d1ac-49f3-b38e-2624e13c2988, abstract = {{<p>Huntington's disease (HD) is a neurodegenerative disorder caused by CAG expansions in the huntingtin (HTT) gene. Modelling Huntington's disease is challenging, as rodent and cellular models poorly recapitulate the disease as seen in aging humans. To address this, we generated induced neurons (iNs) through direct reprogramming of human skin fibroblasts, which retain age-dependent epigenetic characteristics. HD-iNs displayed profound deficits in autophagy, characterised by reduced transport of late autophagic structures from the neurites to the soma. These neurite-specific alterations in autophagy resulted in shorter, thinner and fewer neurites specifically in HD-iNs. CRISPRi-mediated silencing of HTT did not rescue this phenotype but rather resulted in additional autophagy alterations in ctrl-iNs, highlighting the importance of wild type HTT in normal neuronal autophagy. In summary, our work identifies a distinct subcellular autophagy impairment in adult patient derived Huntington's disease neurons and provides a new rational for future development of autophagy activation therapies.</p>}}, author = {{Pircs, Karolina and Drouin-Ouellet, Janelle and Horváth, Vivien and Gil, Jeovanis and Rezeli, Melinda and Garza, Raquel and Grassi, Daniela A and Sharma, Yogita and St-Amour, Isabelle and Harris, Kate and Jönsson, Marie E and Johansson, Pia A and Vuono, Romina and Fazal, Shaline V and Stoker, Thomas and Hersbach, Bob A and Sharma, Kritika and Lagerwall, Jessica and Lagerström, Stina and Storm, Petter and Hébert, Sébastien S and Marko-Varga, György and Parmar, Malin and Barker, Roger A and Jakobsson, Johan}}, issn = {{1460-2156}}, language = {{eng}}, number = {{9}}, pages = {{3035--3057}}, publisher = {{Oxford University Press}}, series = {{Brain : a journal of neurology}}, title = {{Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease}}, url = {{http://dx.doi.org/10.1093/brain/awab473}}, doi = {{10.1093/brain/awab473}}, volume = {{145}}, year = {{2022}}, }